Pharma-Bio Serv (PBSV) Common Equity (2016 - 2025)
Historic Common Equity for Pharma-Bio Serv (PBSV) over the last 16 years, with Q4 2025 value amounting to $11.9 million.
- Pharma-Bio Serv's Common Equity fell 1313.19% to $11.9 million in Q4 2025 from the same period last year, while for Oct 2025 it was $11.9 million, marking a year-over-year decrease of 1313.19%. This contributed to the annual value of $11.9 million for FY2025, which is 1313.19% down from last year.
- Pharma-Bio Serv's Common Equity amounted to $11.9 million in Q4 2025, which was down 1313.19% from $11.9 million recorded in Q3 2025.
- Pharma-Bio Serv's Common Equity's 5-year high stood at $23.8 million during Q3 2021, with a 5-year trough of $11.9 million in Q4 2025.
- Over the past 5 years, Pharma-Bio Serv's median Common Equity value was $16.0 million (recorded in 2022), while the average stood at $16.0 million.
- In the last 5 years, Pharma-Bio Serv's Common Equity soared by 556.5% in 2021 and then crashed by 3226.47% in 2022.
- Quarter analysis of 5 years shows Pharma-Bio Serv's Common Equity stood at $18.9 million in 2021, then fell by 12.46% to $16.6 million in 2022, then dropped by 2.6% to $16.1 million in 2023, then fell by 14.95% to $13.7 million in 2024, then fell by 13.13% to $11.9 million in 2025.
- Its last three reported values are $11.9 million in Q4 2025, $11.9 million for Q3 2025, and $12.1 million during Q2 2025.